HKSE:01609 (China)
Â
Class H
HK$
143.8
-0.30 (-0.21%)
Aug 21
Business Description
Star Sports Medicine Co Ltd
ISIN : CNE100007KK8
Share Class Description:
HKSE:01609: Class HCompare
Compare
Traded in other countries / regions
01609.Hong Kong IPO Date
2026-05-05Description
Star Sports Medicine Co Ltd is a China-based medical device company specializing in clinical sports medicine solutions. It is principally engaged in the research and development and sales of medical devices and equipment in the field of sports medicine. The product line covers medical implants, surgical equipment and associated medical consumables. The company has only one reportable operating segment, which is the sale of sports medicine products. It derives revenue from the sales of (i) medical implants and (ii) surgical equipment and associated medical consumables, with the majority of revenue generated from the sales of Medical implants. Geographically, the maximum revenue is derived from the Chinese mainland.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 36.04 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.58 | |||||
Interest Coverage | 494.3 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 39.6 | |||||
3-Year EBITDA Growth Rate | 51.4 | |||||
3-Year EPS without NRI Growth Rate | 56 | |||||
3-Year FCF Growth Rate | 37 | |||||
3-Year Book Growth Rate | 22.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.47 | |||||
9-Day RSI | 52.88 | |||||
14-Day RSI | 50.44 | |||||
3-1 Month Momentum % | -31.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 12.3 | |||||
Quick Ratio | 11.65 | |||||
Cash Ratio | 10.76 | |||||
Days Inventory | 796.9 | |||||
Days Sales Outstanding | 114.53 | |||||
Days Payable | 277.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 74.8 | |||||
Operating Margin % | 40.44 | |||||
Net Margin % | 36.38 | |||||
EBITDA Margin % | 43.22 | |||||
FCF Margin % | 94.93 | |||||
OCF Margin % | 121.38 | |||||
ROE % | 5.59 | |||||
ROA % | 4.81 | |||||
ROIC % | 26.39 | |||||
ROC (Joel Greenblatt) % | 40.71 | |||||
ROCE % | 6 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 151.53 | |||||
PE Ratio without NRI | 114.49 | |||||
PS Ratio | 55.14 | |||||
PB Ratio | 5.23 | |||||
Price-to-Tangible-Book | 5.24 | |||||
Price-to-Free-Cash-Flow | 58.08 | |||||
Price-to-Operating-Cash-Flow | 45.42 | |||||
EV-to-EBIT | 115.19 | |||||
EV-to-EBITDA | 107.3 | |||||
EV-to-Revenue | 46.38 | |||||
EV-to-FCF | 48.85 | |||||
Price-to-Graham-Number | 4.17 | |||||
| Price-to-Net-Current-Asset-Value | 5.91 | |||||
| Price-to-Net-Cash | 6.88 | |||||
Earnings Yield (Greenblatt) % | 0.87 | |||||
FCF Yield % | 1.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Star Sports Medicine Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 143.001 | ||
| EPS (TTM) (HK$) | 0.949 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 50.44 | ||
| 14-Day ATR (HK$) | 13.678798 | ||
| 20-Day SMA (HK$) | 134.32 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 106 - 299 | ||
| Shares Outstanding (Mil) | 54.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Star Sports Medicine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Star Sports Medicine Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Star Sports Medicine Co Ltd Frequently Asked Questions
What is Star Sports Medicine Co Ltd(HKSE:01609)'s stock price today?
The current price of HKSE:01609 is HK$143.80. The 52 week high of HKSE:01609 is HK$299.00 and 52 week low is HK$106.00.
When is next earnings date of Star Sports Medicine Co Ltd(HKSE:01609)?
The next earnings date of Star Sports Medicine Co Ltd(HKSE:01609) is .
Does Star Sports Medicine Co Ltd(HKSE:01609) pay dividends? If so, how much?
Star Sports Medicine Co Ltd(HKSE:01609) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Star Sports Medicine Co Ltd
No articles.